Despite consistent improvements in glycemic outcomes across simulations, real-world adoption is lagging. The study finds that ...

A year to the day after declaring the FDA’s clearance of its automated insulin pump, Sequel Med Tech announced that its first connected continuous glucose monitor will be Abbott’s FreeSty | Greenlit ...

Beta Bionics Inc.’s concept of an artificial pancreas that regulates blood sugar levels in people with type 1 diabetes (T1D) ...

People who have diabetes will receive an opportunity to learn more about monitors, pumps and other devices during Columbus Community Hospital’s Spring Diabetes Technology Fair. The event will take ...

Type 1 and type 2 diabetes require different approaches. Discover the 9 essential distinctions that affect daily management ...

The "Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes: Insulin & GLP-1, Continuous Glucose Monitoring and 7 more" ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Embecta faces headwinds from new insulin delivery technologies and GLP-1 drugs, but its valuation is compelling with a ~44% free cash flow yield on guided free cashflow. EMBC's end market is ...

The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income countries.

The places where you inject insulin may depend on the type of syringe or prefilled insulin pen you use. You should rotate these injection sites on your skin each time you inject insulin.

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...